DUBLIN--(BUSINESS WIRE)--The "Global 3D Bioprinters Market - Industry Trends, Opportunities and Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.
Global 3D Bioprinters market is projected to grow at a CAGR of 48.30% during the forecast period to reach a total market size of US$86.063 million in 2023 from US$12 million in 2018.
3D bioprinter is an extended version of a conventional 3D printer which is used to produce living tissue, bones, blood vessels, and organs for medical, research, and testing purposes. Widening demand-supply gap in organ transplantation is the major driver of global 3D bioprinters market.
Major market players are increasingly investing in R&D activities to test and develop innovative applications of 3D bioprinters in the field of tissue engineering and regenerative medicine. This is further boosting the growth of 3D bioprinters market. Stringent regulations regarding the use of animals for testing purposes are another factor that is fuelling the demand for 3D bioprinters worldwide.
However, the ethical issue regarding the use of organs and tissues generated in labs will hamstring the growth of 3D bioprinters market during the forecast period.
- Synthetic and Semi-Synthetic
- Soft Tissue
- Hard Tissue
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. 3D Bioprinters Market Forecast by Technology (US$ million)
6. 3D Bioprinters Market Forecast by Material (US$ million)
7. 3D Bioprinters Market Forecast by Application (US$ million)
8. 3D Bioprinters Market Forecast by Geography (US$ million)
9. Competitive Intelligence
10. Company Profiles
- Organovo Holdings, Inc.
- CELLINK AB
For more information about this report visit https://www.researchandmarkets.com/research/h4xcnk/global_3d?w=4